Mutual Funds & ETFs
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Reuters: Company News
March 04, 2013 at 09:07 AM EST
BRIEF-Celgene down in premarket after psoriasis drug trial results
NEW YORK, March 4 (Reuters) - Celgene Corp : * Down 2.2 percent to $103.26 in premarket after psoriasis drug trial results
Read More >>
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here